<DOC>
	<DOCNO>NCT02006888</DOCNO>
	<brief_summary>The purpose study determine whether IBI-10090 injection effective treatment inflammation associate cataract surgery .</brief_summary>
	<brief_title>The Efficacy Safety IBI-10090 Treatment Inflammation Associated With Cataract Surgery</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Cataract</mesh_term>
	<criteria>1 . The patient must provide write informed consent signing Informed Consent approve Institutional Review Board ( IRB ) . 2 . Male female patient least 40 year age schedule unilateral cataract surgery phacoemulsification posterior chamber intraocular lens implantation . 3 . The patient must demonstrate best correct visual acuity ( BCVA ) 20/3020/200 ( glare test , necessary ) study eye well 20/200 fellow eye . 4 . The patient must consider Investigator visual acuity potential great 20/30 study eye . 5 . The patient must corneal endothelial cell count specular microscopy study eye least 2000 cells/mm2 normal cell morphology . 6 . A female patient childbearing potential ( premenopausal medical history ) must negative pregnancy test Day 0 use effective method birth control ( although birth control method 100 % effective , follow consider effective mean contraception : surgical sterilization , use oral contraceptive , barrier contraception use either condom diaphragm spermicidal gel , intrauterine device , contraceptive hormone implant patch ) Screening duration study . 7 . The patient must willing able understand comply study procedure communicate meaningfully study personnel . Key 1 . Patients use ocular , topical oral corticosteroid within 7 day prior Day 0 . 2 . Patients receive periocular corticosteroid injection study eye 3 month prior screen . 3 . Patients receive intravitreal corticosteroid delivery vehicle ( e.g. , Retisert , Ozurdex , Iluvien ) study eye time . 4 . Patients anticipate require treatment corticosteroid route , except inhalation , study . 5 . Patients allergy hypersensitivity dexamethasone . 6 . Patients know steroid responder ( corticosteroidrelated intraocular pressure elevation either eye ) . 7 . Patients use topical ocular NSAIDs study eye within 15 day prior Day 0 . 8 . Patients undergone prior intraocular ( nonlaser ) surgery study eye within 6 month prior screen . 9 . Patients undergone prior intraocular laser surgery study eye within 3 month prior screen . 10 . Patients plan intraocular laser surgery study eye duration study .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Inflammation</keyword>
	<keyword>cataract surgery</keyword>
</DOC>